Publication: Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
| dc.contributor.author | García Castillo, Elena | |
| dc.contributor.author | Alonso Pérez, Tamara | |
| dc.contributor.author | Peláez, Adrián | |
| dc.contributor.author | Pérez González, Patricia | |
| dc.contributor.author | Miravitlles, Marc | |
| dc.contributor.author | Alfageme, Inmaculada | |
| dc.contributor.author | Casanova, Ciro | |
| dc.contributor.author | Cosío, Borja G | |
| dc.contributor.author | de Lucas, Pilar | |
| dc.contributor.author | García-Río, Francisco | |
| dc.contributor.author | Rodríguez González-Moro, José Miguel | |
| dc.contributor.author | Soler-Cataluña, Juan José | |
| dc.contributor.author | Sánchez, Guadalupe | |
| dc.contributor.author | Soriano, Joan B | |
| dc.contributor.author | Ancochea, Julio | |
| dc.date.accessioned | 2025-01-22T13:56:05Z | |
| dc.date.available | 2025-01-22T13:56:05Z | |
| dc.date.issued | 2023-03 | |
| dc.description | IBERPOC study funding was obtained from Boehringer Ingelheim, Spain, S.A. EPISCAN study was a GSKsponsored GlaxoSmithKline Spain. EPISCAN II study was a GSK sponsored study, registered in ClinicalTrials.gov Identifier: NCT01122758. | |
| dc.description.abstract | Introduction: We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints. Methods: We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN). Results: COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%-23.2%) in 1997 to 8.8% (95% CI 8.2%-9.5%) in 2017, a 59.2% decline (p<0.001). In 2007, the prevalence was 7.7% (95% CI 6.8%-8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40-49 yrs and 50-59 yrs) and also higher in women than in men in all three studies (p<0.05). Conclusions: We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40-69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations. | |
| dc.description.peerreviewed | Sí | |
| dc.format.number | (3) | |
| dc.format.page | 142-151 | |
| dc.format.volume | 59 | |
| dc.identifier.citation | Arch Bronconeumol. 2023 Mar;59(3):142-151. | |
| dc.identifier.journal | Archivos de Bronconeumología | |
| dc.identifier.pubmedID | 36549937 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/26099 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.publisherversion | https://10.1016/j.arbres.2022.11.014 | |
| dc.repisalud.institucion | CNIC | |
| dc.repisalud.orgCNIC | CNIC::Unidades técnicas::Bioinformática | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | COPD | |
| dc.subject | Prevalence | |
| dc.subject | Smoking | |
| dc.subject | Spain | |
| dc.subject | Spirometry | |
| dc.subject | Underdiagnosis | |
| dc.title | Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Trends of COPD in Spain_Arch Bronconeumol_2023.pdf
- Size:
- 1.93 MB
- Format:
- Adobe Portable Document Format


